Rhythm Mild‐Temperature Photothermal Therapy Enhancing Immunogenic Cell Death Response in Oral Squamous Cell Carcinoma
Advanced Healthcare Materials · 2023-03 · 12 (6)
DOI: 10.1002/adhm.202202360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 07.12.2022. Verfasst von Jianchuan Ran und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Stomatological Hospital, Medical School of Nanjing University, 30 Zhongyang Road, Nanjing, 210008, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Nanoparticles, Head and Neck Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
The low antitumor efficiency and unexpected thermo‐tolerance activation of mild‐temperature photothermal therapy (mPTT) severely impede the therapeutic efficacy, thereby the implementation of reasonable mPTT procedure to improve antitumor efficiency is of great significance for clinical transformation. Herein, a rhythm mPTT with organic photothermal nanoparticles (PBDB‐T NPs) is demonstrated, synergistically increasing tumor elimination and intense immunogenic cancer cell death (ICD) to elicit tumor‐specific immune responses for tumor treatment. Specifically, PBDB‐T NPs are characterized by favorable biocompatibility, excellent and controllable photothermal properties, exhibit the properties of noninvasive diagnostic imaging, and effective mPTT against oral squamous cell carcinoma (OSCC). Encouragingly, a temperature‐dependent release of damage‐associated molecular patterns (DAMPs) is discovered during the mPTT‐induced ICD. Meanwhile, orchestrated rhythm mPTT referring to radiotherapy procedure amplifies and balances antitumor efficiency and abundant DAMPs generation to gain optimal immune activation within clinical‐recommended hyperthermia temperature compared with conventional PTT. The in vitro and in vivo results show that the rhythm mPTT unites the killing effect and ICD induction, generating strong mPTT efficacy and active tumor‐specific adaptive immune responses. The study offers a promising strategy and a new opportunity for the clinical application of mPTT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nanjing Stomatological Hospital, Medical School of Nanjing University, 30 Zhongyang Road, Nanjing, 210008, China.
- Department of Oral Medicine, Nanjing Stomatological Hospital, Medical School of Nanjing University, 30 Zhongyang Road, Nanjing, 210008, China.
- Institute of Translational Medicine, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, China.
- Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, 310014, China.
ORCID-Profile: Jianchuan Ran
Förderung
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Ran, J., Liu, T., Song, C., Wei, Z., Tang, C., Cao, Z., Zou, H., Zhang, X., Cai, Y., & Han, W. (2023). Rhythm Mild‐Temperature Photothermal Therapy Enhancing Immunogenic Cell Death Response in Oral Squamous Cell Carcinoma. Advanced Healthcare Materials, 12(6). https://doi.org/10.1002/adhm.202202360
Vancouver
Ran J, Liu T, Song C, Wei Z, Tang C, Cao Z, et al. Rhythm Mild‐Temperature Photothermal Therapy Enhancing Immunogenic Cell Death Response in Oral Squamous Cell Carcinoma. Advanced Healthcare Materials. 2023;12(6). doi:10.1002/adhm.202202360
BibTeX
@article{Ran2023,
author = {Ran, Jianchuan and Liu, Tao and Song, Chuanhui and Wei, Zheng and Tang, Chuanchao and Cao, Zichen and Zou, Huihui and Zhang, Xinyu and Cai, Yu and Han, Wei},
title = {Rhythm Mild‐Temperature Photothermal Therapy Enhancing Immunogenic Cell Death Response in Oral Squamous Cell Carcinoma},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {6},
doi = {10.1002/adhm.202202360}
}
EUVIMED